The Anatomy of Fear


Fear: it is something we have all experienced before. But have you ever stopped to think how we know to be afraid of something, and for that matter, how and why we respond to that fear? Research has shown that the major parts of the brain that process what we call fear and anxiety include the amygdala, the periaqueductal gray and the hippocampus. The following paper discusses the anatomy, the functions, and the connections between the first two of these structures, the amygdala and the PAG.

The amygdala is a large nuclear complex located in the dorsomedial portion of the temporal lobe. It is divisible into a series of nuclei with two major divisions: the corticomedial division and the basolateral division. The corticomedial group is composed of the nucleus corticalis and the nucleus medialis as well as a number of smaller cell masses. The basolateral group is composed of the nucleus lateralis, the nucleus basalis, the nucleus basalis accessorius, and the nucleus centralis. Other names for these subdivisions are the lateral nucleus, the basal nucleus, the accessory basal nucleus and the central nucleus respectively (Nieuwenhuys, Voogd, and Huijzen 191).


According to The Central Nervous System, the afferent projections of the amygdala can be placed into one of the following four groups:

  1. fibers originating from the olfactory bulb and the olfactory part of the cerebral cortex
  2. fibers originating form the preoptic region and from the hypothalamus
  3. afferents directly from the brain stem
  4. fibers from various areas of the cerebral cortex other than the olfactory area.


On the other hand, the efferent projections of the amygdala can be traced to the following areas:

  1. septopreopticohypothatlmic continum
  2. dorsal thalamus
  3. cell groups of the brain stem
  4. a number of areas in the cerebral cortex


Although the anatomy of the amygdala is important, the function of this structure and its subdivisions is also important. To determine the specific functions or responses of the amygdaloid nuclei, tests can be performed that specifically target the desired area. For example, certain nuclei can be excited via electrical stimulation or destroyed via lesions. The effects of these procedures can be studied physiologically. But first, let us look at the amygdala as a whole.

Electrical stimulation of the amygdala, specifically the central nucleus, produces a series of behavioral and anatomical changes nearly identical to those produced in a state of fear. Targeting the central nucleus can still give results for the entire amygdala because it receives input from each of the other nuclei. Thus, electrical stimulation of the central nucleus evokes increased heart rate and blood pressure, ulceration, urination and/or defecation, increased respiration, increased vigilance, increased startle, freezing facial expressions of fear and corticosteroid response depending on the specific anatomical target of the amygdala. Thus, activation of the amygdala elicits a set of behaviors resembling fear responses by projecting to a number of target areas such as the hypothalamus, the central grey and many of the cranial nerves (Davis 355-357).

Other studies specifically targeting the lateral and basolateral nuclei have determined their individual functions as well. Most of these studies deal with formation of memories of fear using classical conditioning where an electrical shock is paired with a noise or light. In one such experiment, to determine the amygdaloid nuclei's role in this type of memory formation, researchers systematically destroyed, via lesions, specific areas of the brain. If these lesions in any way impeded the fear conditioning, it was assumed that this area is necessary in memory formation concerning fear and anxiety.

In this experiment, the auditory cortex was destroyed and it had no effect on the fear conditioning of the rats being used. Lesions were then made in the auditory thalamus and midbrain. These resulted in complete elimination of the rat's conditioning. These results suggested that once the sound stimulus was processed in the auditory thalamus and midbrain it traveled to another region other that the auditory cortex and this connection is what results in physiological responses to the stimuli. Researchers then traced fibers from the thalamus to subcortical regions and discovered that only destruction of those leading to the amygdala had an effect on fear conditioning.

Following this pattern, the experiment then involved discovering the specific functions and connections between the amygdaloid nuclei. Previous research had already revealed that lesions of the central nucleus had an effect on heart rate, respiration, and vasodilation. This experiment also showed that lesions of this nucleus prevented a rise in blood pressure and freezing.

However, researchers also learned that the central nucleus is not directly connected to the auditory thalamus. In fact, it is the lateral nucleus that receives sensory information from the auditory thalamus which in turn sends these signals to the basolateral, basomedial or accessory basal nucleus which then communicates with the central nucleus. It is the central nucleus that then connects to areas in the brain stem that elicit physiological responses (LeDoux 50-57).

Another experiment produced similar results, this time using a visual stimulus. Here, infusions of N-methyl-D-aspartate were used to create lesions in the lateral and basolateral nuclei. Their experiments also revealed that it is the lateral or basolateral nuclei ( or both ) that relays visual information to the central nucleus. It was also discovered that lesions of the most anterior portion of the basolateral nucleus blocked increased startle levels normally produced by a series of footshocks. Thus, it is this portion of the basolateral nucleus that processes shock information. Overall, this study reveals that it is the lateral and basolateral amygdaloid nuclei that are vital for the expression of fear-potentiated startle and the anterior basolateral nuclei in increasing startle with a series of shocks (Sananes and Davis 72-79).

The periaqueductal grey is another major structure involved in the processing of fear. It is a large structure located in the midbrain, consisting of small to medium neurons surrounding the aqueduct of Silvus, otherwise known as the cerebral aqueduct. The periaqueductal grey runs from the posterior commisure rostrally to the locus coeruleus caudally. Anatomically, there are two ways to divide it: by cell type or on the basis of its anatomical connections and functional representation of cardiovascular and behavioral functions. In this later method, the periaqueductal grey is divided into four major vertical columns situated dorsomedial, dorsolateral, lateral and ventrolateral to the aqueduct.Research by Betty Hamilton investigated the cytoarchitectual subdivisions of the PAG in the cat. These studies found that the neurons of the PAG are all relatively small, ranging in size from eight to thirty micrometers in diameter. These neurons can be divided into three different types (I, II, and III). Each type can be found in different regions of the PAG and are distinguishable by their size and other cytological characteristics.

Class I neurons are the smallest of the three types. They average 18 micrometers in length and 8.5 micrometers in width. After Nissel staining the cells appear darkly stained with an axon projecting from one end of the cell. The nucleus is rather large, oval in shape and stains slightly lighter that the surrounding cytoplasm of the cell. The cell itself is spindle shaped with the nucleus located in the center taking up the entire width of the cell. Nissel substances are uniformly distributed and are not found in clumps. Usually, class I neurons are found in the innermost regions of the PAG, called the nucleus medialis. Overall this area has a small population of neurons.

Class II neurons are slightly larger with the average diameter being between 11 and 12.2 micrometers. They are fusiform or spherical in shape. The nucleus in this cell type is usually irregularly shaped. The axon of these cells is located in the central region, not at a pole as in class I. Class II neurons generally have several dendrites. The Nissel substances are arranged in clumps which are evenly distributed in the cytoplasm. Class II neurons aggregate in the area just dorsal to the cerebral aqueduct named the nucleus dorsalis along with a large number of glial cells.

Class III neurons are the largest of the tree types, with the average length and width measuring 18.9 and 15 micrometers, respectively. These cells are generally fusiform, spherical, or triangular in shape and have a sparse amount of Nissel substance in their cytoplasm. This later fact attributes to the fact that these cells stain very lightly. In most cases, one axon and one dendrite can be identified. However, in the cases where there is one axon and two dendrites, one of the dendrites is located at the opposite pole as the axon and the other in the central region. The nucleus is large in class III neurons, it is round, centrally located, and darkly staining. These cells are found in the outer layer of the periaqueductal grey known as the nucleus lateralis also along with a large number of glial cells (Hamilton 1-7).

The periaqueductal grey can also be divided into four major longitudinal columns. These columns are located dorsomedial, dorsolateral, lateral, and ventrolateral to the cerebral aqueduct. The boundaries of these columns are based on both anatomical and functional characteristics. These columns are not of uniform width going caudally to rostrally. For example, the dorsomedial and ventrolateral columns narrow as they travel caudally (Carrive 27-44).


The periaqueductal grey receives afferents from the following structures: the amygdala, nucleus stria terminalis, dorsal hypothalamus, midline thalamus, periventricular grey and the dorsolateral and ventrolateral midbrain tegmentum. As for PAG efferents, the majority of the fibers leaving the PAG terminate in the parabrachial nuclei, reticular formation, trigeminal motor nucleus and nucleus ambiguus (Jurgens and Pratt 367).

Generally, the periaqueductal grey is known to be involved in some sort of protection or defensive reactions. The research team of Jurgens and Pratt investigated the role of the PAG in vocal expression of emotion. Introducing dummy leopards to a group of squirrel monkeys was effective in producing a fear elicited yapping calls. The team found that even the smallest lesions of the PAG abolished the yapping call. Similarly, shrieking calls were produced by gripping the squirrel monkeys forcibly. These calls were also abolished, although the lesions of the PAG had to be larger in this case (Jurgens and Pratt 367-377).

Another study investigated the role of the PAG in feline active defense and quiet biting attack behavior. Affective defense behavior involves piloerection, retraction of ears, baring of teeth, arching of back, pupillary dilation, growling, hissing, unsheathing of claws, paw striking, urination, and sympathetic cardiovascular reactions . Conversely, quiet biting attack behavior involves the stalking of an anesthetized rat followed by a bite on the back of its neck. In this type of behavior, there is no autonomic system activation except for minimal pupillary dilation. In this study, affective defense behavior was elicited via both electrical and chemical stimulation of the dorsal half of the central grey. However, quiet biting attack behavior was elicited from the ventral half of the PAG. Thus, this study discovered two different pathways of fibers from the PAG that are associated with affective defense behavior and quiet biting attack behavior separately, in other words, a functional delineation (Shaikh, Barrett, and Siegel 9-23).

In another set of experiments, the function of particular columns of the periaqueductal grey were ascertained. Specifically, the lateral and ventrolateral columns were studied because they contain "topographically distinct groups of neurons" which upon stimulation result in different forms of defensive behaviors. Both play a vital role in the somatic and autonomic components of defensive behavior. The results show that injection of excitatory amino acids, which excite the cell body but not the axon, into the lateral column increases somatic and autonomic reactions. These reactions include elevated blood pressure, elevated heart rate, increased vocalization, and increased hindlimb movement. These last two reactions are characteristic of "fight" and "flight" respectively.

In contrast, when the ventrolateral column of the PAG was injected with an excitatory amino acid, autonomic and somatic activity decreased. This included a drop in heart rate and blood pressure. Thus these two columns seem to oppose each other functionally. In the lateral column alone, there seems to be both a "fight" or threat display area and a "flight" area. This was demonstrated again via excitatory amino acids. When the "fight" area was stimulated, blood flow was constricted in the hindlimb but was increased to the face. In contrast, when the "flight" area was stimulated, blood flow to the hindlimb increased whereas blood flow to the face was decreased. It is believed that the lateral column of the PAG causes these "fight or flight" reactions in response to cutaneous, superficial stimuli. Thus, a rise in blood pressure, heart rate, and defensive posture is appropriate because it prepares the subject physically to either fight or run. On the other hand, the ventrolateral column is believed to elicit reactions caused by deeper visceral somatosensory inputs. This could be described as an inescapable visceral pain or extreme muscle fatigue. Therefore, a reaction that causes decreased movement and muscle tone seems appropriate under these conditions (27-44).

So far, the anatomy and independent function of the amygdala and the PAG have been discused. Therefore, the only topic that remains in this overview of the anatomy of fear is the connections, both physical and anatomical, between these two structures.

Different tracing methods have been used to determine the existence of a connection between the amygdala and the periaqueductal grey. For example, one study used tritium-labelled leucine (Jurgens and Pratt 374). This was injected into the amygdala and inspection of the PAG revealed a direct projection. Another experiment used c-fos immunoreactivity as a marker. When the animals were exposed for fifteen minutes to an elevated plus maze, an animal model of anxiety, c-fos immunoreactivity appeared in the piriform cortex. This sends massive input to the amygdala, in several amygdaloid nuclei in the periventricular system along the anteroposterior extension of the hypothalamus and its projections to the dorsal PAG and other structures (Graeff et. al. 123).

According to Micheal Davis, the central nucleus of the amygdala projects to a region of the central grey and the effect of amygdaloid stimulation is cessation of behavior in the form of freezing. In further research, following infusion of a retrograde tracer into the dorsal PAG, the presence of met-enkephalin and Fluoro-Gold within the central and lateral nucleus of the amygdala were found (Shaikh, Lu, Seigel 116-117).

So, there is evidence demonstrating that the dorsal half of the PAG elicits affective defense behavior. Yet stimulation of the amygdala somehow suppresses this behavior via some sort of connection. Research led by Majid B. Shaikh revealed exactly how the amygdala suppresses this affective defense behavior at the level of the PAG. This research showed that the suppression is mediated through mu and delta opioid peptides at the level of the midbrain PAG. They believed that the source of the opioid afferents to the PAG is the central nucleus of the amygdala. This belief was based on the following information: the central nucleus suppresses this behavior when stimulated, the central nucleus contains a large number of neurons that immunoreact with enkephalins, and there is a direct projection from the central nucleus to the PAG.

This research provided evidence that when an opioid receptor blockade is set up in the PAG, the suppressive effects of the amygdala were totally eliminated. The researchers first used the non-specific opioid antagonist naxalone and this completely blocked the suppressive effect. Furthermore, suppression was eliminated with B-FNA, a specific mu receptor antagonist. However, when ICI 174,864, a specific receptor antagonist was used, the suppressive effects of the amygdala was unchanged. Thus, the PAG must receive afferents from another source besides the amygdala that operates via delta receptors (Shaikh, Lu, Siegel 109-117).

The brain system that deals with fear and anxiety is thus a very complicated one. The amygdala and the periaqueductal grey are two main constituents in this system, representing the rostral and caudal ends respectively. Both the amygdala and the PAG can be broken down, and each of these subdivisions serves an important function in the processing of and reaction to stimuli producing fear. Connections between these two structures also play an important role in reaction to fear. Obviously, innumerable studies have been conducted on fear and its anatomy, but like everything else, there is still a lot yet to learn.

Works Cited

Carrive, Pascal. "The Periaqueductal Gray and Defensive Behavior:

Davis, Micheal. "The Role of the Amygdala in Fear and Anxiety."

Graeff, Frederico G., Maria Cristina L. Silveira, Regina L.

Hamilton, Betty L. "Cytoarchitectural Subdivisions of the

Jurgens, U. and R. Pratt. "Role of the Periaqueductal Grey in

Kim, Jeansok J., Richard A. Rison, and Micheal S. Fanselow.

LeDoux, Joseph E. "Emotion, Memory and the Brain." Scientific

Nieuwenhuys, Rudolf, Jan Voogd, and Christiaan van Huijzen. The

Sananes, Catherine B. and Micheal Davis. "N-Methyl-D-Aspartate

Shaikh, Majid B., Chang-Lin Lu, and Allan Siegel. "An

Shaikh, Majid B., Jeannette A. Barrett, and Allan Siegel. "The